Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19

Clinical trial NCT04659109 · COMPLETED

Trial details

NCT number: NCT04659109
Sponsor: Acticor Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV Infection Acute Respiratory Distress Syndrome COVID-19 ARDS

Start date: 2020-12-16
Primary completion: 2021-08-06
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.